ity further, the proteins work in coordinated teams, requiring their relevant members to be in the right place at the right time if they are to generate the right response.
The Novo Nordisk Foundation Center for Protein Research will have five principal investigators, two of whom have already been appointed. One is Matthias Mann, a director at the Max Planck Institute of Biochemistry in Martinsried near Munich. Mann is a pioneer of protein mass spectrometry, a key proteomics technology. This technique, which smashes proteins into tiny fragments before reconstructing them by computer for identification and further study, benefits from the sort of large-scale computing power and bioinformatics capability a large centre can provide. Mann will not quit his current position but will oversee independent groups working on biological mechanisms such as signal transduction and on stem-cell biology, particularly in relation to diseases such as cancer.
The other lead investigator so far named is Søren Brunak, from the Technical University of Denmark in Copenhagen. Brunak runs one of the largest bioinformatics departments in Europe. At the new centre he will focus on integrating what is known about creatures' physical characteristics with proteomic and genomic information in order to understand how different protein complexes may relate to disease. "We'll have access to Scandinavian biobanks and electronic patient records renowned for their high quality, " says Brunak, "and we'll find more by text mining scientific publication databases. "
Mann and Brunack already collaborate in the Interaction Proteome Project, which is funded by the European Commission. "We've merged our skills before -for example we've created Denmark launches big push for protein power
The discovery of a virus that may have killed three transplant recipients in Australia could mark a dramatic acceleration in the speed at which new pathogens can be identified. But it raises concerns that the ease with which such suspects can now be found could lead to researchers overlooking the need to firmly establish them as the cause of the disease in question. Fingering the wrong microbe could lead to inappropriate treatment or divert attention away from the real cause. what we call a 'temporal interactome' in one cellular compartment, the human nucleolus, " comments Brunack, referring to studies of patterns in protein interaction studied over time as well as in space.
Building work for the centre will start immediately and it will open in 2008 with a hundred or so staff; some research projects will begin in other premises before this. ■
Alison Abbott
The research centre being built in Copenhagen will offer the computing power needed to resolve complex protein interactions.
